These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy. Weir SJ; Patton L; Castle K; Rajewski L; Kasper J; Schimmer AD J Clin Pharm Ther; 2011 Apr; 36(2):128-34. PubMed ID: 21366640 [TBL] [Abstract][Full Text] [Related]
5. Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines. Wu J; Liu H; Zhang G; Gu L; Zhang Y; Gao J; Wei Y; Ma Z PLoS One; 2016; 11(8):e0161509. PubMed ID: 27551974 [TBL] [Abstract][Full Text] [Related]
6. Repositioning the Old Fungicide Ciclopirox for New Medical Uses. Shen T; Huang S Curr Pharm Des; 2016; 22(28):4443-50. PubMed ID: 27238364 [TBL] [Abstract][Full Text] [Related]
8. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK. Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756 [TBL] [Abstract][Full Text] [Related]
9. The antitumor activity of the fungicide ciclopirox. Zhou H; Shen T; Luo Y; Liu L; Chen W; Xu B; Han X; Pang J; Rivera CA; Huang S Int J Cancer; 2010 Nov; 127(10):2467-77. PubMed ID: 20225320 [TBL] [Abstract][Full Text] [Related]
10. Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity. Sen S; Hassane DC; Corbett C; Becker MW; Jordan CT; Guzman ML Exp Hematol; 2013 Sep; 41(9):799-807.e4. PubMed ID: 23660068 [TBL] [Abstract][Full Text] [Related]
11. Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies. Minden MD; Hogge DE; Weir SJ; Kasper J; Webster DA; Patton L; Jitkova Y; Hurren R; Gronda M; Goard CA; Rajewski LG; Haslam JL; Heppert KE; Schorno K; Chang H; Brandwein JM; Gupta V; Schuh AC; Trudel S; Yee KW; Reed GA; Schimmer AD Am J Hematol; 2014 Apr; 89(4):363-8. PubMed ID: 24273151 [TBL] [Abstract][Full Text] [Related]
12. Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis. Braun JA; Herrmann AL; Blase JI; Frensemeier K; Bulkescher J; Scheffner M; Galy B; Hoppe-Seyler K; Hoppe-Seyler F Int J Cancer; 2020 Jan; 146(2):461-474. PubMed ID: 31603527 [TBL] [Abstract][Full Text] [Related]
13. Translational downregulation of HSP90 expression by iron chelators in neuroblastoma cells. Sidarovich V; Adami V; Gatto P; Greco V; Tebaldi T; Tonini GP; Quattrone A Mol Pharmacol; 2015; 87(3):513-24. PubMed ID: 25564462 [TBL] [Abstract][Full Text] [Related]
14. Targeting the Wnt/beta-catenin pathway in multiple myeloma. Schmeel LC; Schmeel FC; Kim Y; Endo T; Lu D; Schmidt-Wolf IG Anticancer Res; 2013 Nov; 33(11):4719-26. PubMed ID: 24222106 [TBL] [Abstract][Full Text] [Related]
15. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans. Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671 [TBL] [Abstract][Full Text] [Related]
16. Reposition of the Fungicide Ciclopirox for Cancer Treatment. Huang Z; Huang S Recent Pat Anticancer Drug Discov; 2021; 16(2):122-135. PubMed ID: 33573561 [TBL] [Abstract][Full Text] [Related]
17. Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway. Zhou H; Shen T; Shang C; Luo Y; Liu L; Yan J; Li Y; Huang S Oncotarget; 2014 Oct; 5(20):10140-50. PubMed ID: 25294812 [TBL] [Abstract][Full Text] [Related]
18. Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model. Kim Y; Schmidt M; Endo T; Lu D; Carson D; Schmidt-Wolf IG In Vivo; 2011; 25(6):887-93. PubMed ID: 22021681 [TBL] [Abstract][Full Text] [Related]
19. The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma. Kamihara Y; Takada K; Sato T; Kawano Y; Murase K; Arihara Y; Kikuchi S; Hayasaka N; Usami M; Iyama S; Miyanishi K; Sato Y; Kobune M; Kato J Oncotarget; 2016 Sep; 7(39):64330-64341. PubMed ID: 27602957 [TBL] [Abstract][Full Text] [Related]
20. Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Zarember KA; Cruz AR; Huang CY; Gallin JI Antimicrob Agents Chemother; 2009 Jun; 53(6):2654-6. PubMed ID: 19307370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]